CyDex Pharmaceuticals Overview

  • Founded

  • 1993

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 32

Employees
  • Latest Deal Type

  • M&A

  • Latest Deal Amount

  • $35.5M

CyDex Pharmaceuticals General Information

Description

Provider of drug delivery technology. The company's drug delivery technology uses four Captisol-enabled products commercialized by Pfizer and Bristol-Myers Squibb (BMS) to address asthma, depression, allergy, cancer and arrhythmia disease states.

Contact Information

Website
www.captisol.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Parent Company
Ligand Pharmaceuticals
Primary Office
  • 10513 West 84th Terrace
  • Lenexa, KS 66214
  • United States
+1 (913) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CyDex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 26-Jan-2011 $35.5M 0000 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC 24-Mar-2010 000.00 0000 Completed Generating Revenue
3. IPO 28-Oct-2008 0000 Cancelled Clinical Trials - Phase 2
2. Early Stage VC (Series B) 17-Aug-2004 $17M $29M 000.00 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 11-Oct-2000 $12M $12M 000.00 Completed Clinical Trials - Phase 2
To view CyDex Pharmaceuticals’s complete valuation and funding history, request access »

CyDex Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00 00 00 00 00 0.000
Series A 16,464,622 $0.010000 7% $0.73 $0.73 1x $0.73 15.99%
To view CyDex Pharmaceuticals’s complete cap table history, request access »

CyDex Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of drug delivery technology. The company's drug delivery technology uses four Captisol-enabled products commerc
Drug Delivery
Lenexa, KS
32 As of 2010
0000
00.00 0000-00-00
000000&0 0000

00000

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nu
0000 00000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CyDex Pharmaceuticals Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000 000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
You’re viewing 1 of 1 competitors. Get the full list »

CyDex Pharmaceuticals Patents

  • 380

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 18

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

CyDex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2019532927-A Formulation containing acetaminophen and sulfoalkyl ether cyclodextrin Pending 16-Sep-2016 00000000 0
EP-3512511-A4 Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin Pending 16-Sep-2016 0000000000 0
EP-3512511-A1 Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin Pending 16-Sep-2016 00000000
US-20190255000-A1 Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin Pending 16-Sep-2016 0000000000
CA-3036989-A1 Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin Pending 16-Sep-2016 A61K31/167
To view CyDex Pharmaceuticals’s complete patent history, request access »

CyDex Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CyDex Pharmaceuticals Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Clariden Investment Venture Capital Minority 000 0000 000000 0
Eastman Ventures Corporate Venture Capital Minority 000 0000 000000 0
Edelman Financial Services Asset Manager Minority 000 0000 000000 0
Private Equity Direct Finance PE/Buyout Minority 000 0000 000000 0
RiverVest Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial